The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents

被引：10
|
作者：
Rasmussen, LJ
Rasmussen, M
Lützen, A
Bisgaard, HC
Singh, KK
机构：
[1] Johns Hopkins Oncol Ctr, Johns Hopkins Sch Med, Baltimore, MD 21231 USA
[2] Roskilde Univ, Dept Life Sci & Chem, DK-4000 Roskilde, Denmark
来源：
EXPERIMENTAL CELL RESEARCH | 2000年 / 257卷 / 01期
关键词：
mismatch repair (MMR); cyclin B1; alkylating agents; prostate cancer; DU145; LNCaP;
D O I：
10.1006/excr.2000.4865
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DNA damage caused by alkylating agents results in a G2 checkpoint arrest. DNA mismatch repair (MMR) deficient cells are resistant to killing by alkylating agents and are unable to arrest the cell cycle in G2 phase after alkylation damage. We investigated the response of two MMR-deficient prostate cancer cell lines DU145 and LNCaP to the alkylating agent MNNG. Our studies reveal that DU145 cancer cells are more sensitive to killing by MNNG than LNCaP, Investigation of the underlying reasons for lower resistance revealed that the DU145 cells contain low endogenous levels of cyclin B1. We provide direct evidence that the endogenous level of cyclin B1 modulates the sensitivity of MMR-deficient prostate cancer cells to alkylating agents, (C) 2000 Academic Press.
引用
收藏
页码：127 / 134
页数：8
相关论文
共 50 条
  • [31] SENSITIVITY OF HUMAN CELL STRAINS HAVING DIFFERENT ABILITIES TO REPAIR O-6-METHYLGUANINE IN DNA TO INACTIVATION BY ALKYLATING-AGENTS INCLUDING CHLOROETHYLNITROSOUREAS
    SCUDIERO, DA
    MEYER, SA
    CLATTERBUCK, BE
    MATTERN, MR
    ZIOLKOWSKI, CHJ
    DAY, RS
    CANCER RESEARCH, 1984, 44 (06) : 2467 - 2474
  • [32] Syntheses of prodelphinidin B1, B2, and B4 and their antitumor activities against human PC-3 prostate cancer cell lines
    Fujii, Wataru
    Toda, Kazuya
    Matsumoto, Kiriko
    Kawaguchi, Koichiro
    Kawahara, Sei-ichi
    Hattori, Yasunao
    Fujii, Hiroshi
    Makabe, Hidefumi
    TETRAHEDRON LETTERS, 2013, 54 (52) : 7188 - 7192
  • [33] Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus
    Glaab, WE
    Risinger, JI
    Umar, A
    Barrett, JC
    Kunkel, TA
    Tindall, KR
    CARCINOGENESIS, 1998, 19 (11) : 1931 - 1937
  • [34] Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: The predominant role of hMLH1
    Wheeler, JMD
    Beck, NE
    Kim, HC
    Tomlinson, IPM
    Mortensen, NJM
    Bodmer, WF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10296 - 10301
  • [35] Functional capacity of XRCC1 protein variants identified in DNA repair-deficient Chinese hamster ovary cell lines and the human population
    Berquist, Brian R.
    Singh, Dharmendra Kumar
    Fan, Jinshui
    Kim, Daemyung
    Gillenwater, Elizabeth
    Kulkarni, Avanti
    Bohr, Vilhelm A.
    Ackerman, Eric J.
    Tomkinson, Alan E.
    Wilson, David M., III
    NUCLEIC ACIDS RESEARCH, 2010, 38 (15) : 5023 - 5035
  • [36] Cyclin D1 expression and cell cycle response in DNA mismatch repair-deficient cells upon methylation and UV-C damage
    Lützen, A
    Bisgaard, HC
    Rasmussen, LJ
    EXPERIMENTAL CELL RESEARCH, 2004, 292 (01) : 123 - 134
  • [37] Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: Correlation with sensitivity to DNA damaging agents
    Villa, R
    Folini, M
    Perego, P
    Supino, R
    Setti, E
    Daidone, MG
    Zunino, F
    Zaffaroni, N
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (05) : 995 - 1002
  • [38] Quantitative analysis of the effects of iododeoxyuridine and ionising radiation treatment on the cell cycle dynamics of DNA mismatch repair deficient human colorectal cancer cells
    Gurkan-Cavusoglu, Evren
    Schupp, Jane E.
    Kinsella, Timothy J.
    Loparo, Kenneth A.
    IET SYSTEMS BIOLOGY, 2013, 7 (04) : 114 - 124
  • [39] Inhibition of the human apurinic/apyrimidinic endonuclease (Ape1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone
    Luo, MH
    Kelley, MR
    ANTICANCER RESEARCH, 2004, 24 (04) : 2127 - 2134
  • [40] Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
    Ersvaer, Elin
    Kildal, Wanja
    Vlatkovic, Ljiljana
    Cyll, Karolina
    Pradhan, Manohar
    Kleppe, Andreas
    Hveem, Tarjei S.
    Askautrud, Hanne A.
    Novelli, Marco
    Waehre, Hakon
    Liestol, Knut
    Danielsen, Havard E.
    MODERN PATHOLOGY, 2020, 33 (05) : 905 - 915
12345